EAGEN POSTGRADUATE COURSE Gastric cancer: From bench to bedside Nantes, France, Under auspices of the ESDO and EHMSD IMAD & DHU Oncogreffe, CHU de Nantes 17-18 June 2016 Local organiser Pr Tamara Matysiak-Budnik Logistic organization AS.CONNECT évènement Consacrez-vous à l'essentiel! Tel. +33 2 40 20 15 95 www.asconnect-evenement.fr
Chers Collègues, Au nom du comité local d organisation et de l EAGEN (European Association for Gastroenterology, Endoscopy and Nutrition), nous avons le plaisir de vous inviter au cours international consacré au cancer gastrique. Ce cours vous offrira une opportunité unique de partager les connaissances les plus récentes dans le domaine de cette pathologie grave, tant au niveau de ses aspects cliniques que physiopathologiques, avec les plus grands experts internationaux et français de cette maladie. Nous sommes convaincus que ce sera un évènement important et nous espérons vous accueillir à Nantes à cette occasion. Dear Colleagues, Pr. Tamara MATYSIAK-BUDNIK Pr. Stanislas BRULEY des VARANNES Pr. Emmanuel CORON On behalf of the Local Organising Committee and the European Association for Gastroenterology, Endoscopy and Nutrition (EAGEN), it s our pleasure to invite you to this postgraduate course focused on gastric cancer. This course will give you a great opportunity to share the newest knowledge and experience in this severe pathology, including both its fundamental and clinical aspects, with the colleagues dealing with gastric cancer, through highly interactive and stimulating sessions. We are convinced that this will be an important to welcome all of you in Nantes on this occasion, Program Friday, 17 th of June 8.15-8.30 Welcome and introduction: Stanislas Bruley des Varannes, Tamara Matysiak-Budnik, Tomica Milosavljevic, Philippe Moreau Session N 1 Epidemiology and molecular mechanisms of gastric carcinogenesis Chairman: Eliette Touati & Francis Mégraud 8.30-8.50 Epidemiology of gastric cancer worldwide: Is it really declining? Rolando Herrero, IARC, Lyon, France 8.50-9.00 Vote and discussion 9.00-9.20 New molecular characterisation of gastric cancer José Machado, Porto, Portugal 9.20-9.30 Vote and discussion 9.30-9.50 Cancer immunotherapy: perspectives for gastric cancer Danila Valmori, Nantes, France 9.50-10.00 Vote and discussion 10.00-10.20 Gastric cancer a stem cell disease? Christine Varon, Bordeaux, France 10.20-10.30 Vote and discussion 10.30-11.00 Coffee break
Session N 2 Gastric carcinogenesis: Is gastric cancer an infectious disease? Chairman : Ceu Figueiredo & Peter Malfertheiner 11.00-11.20 H. pylori as the cause of gastric cancer Steffen Backert, Erlangen, Germany 11.20-11.30 Vote and discussion 11.30-11.50 Role of gastric microbiota in the development of gastric cancer Ceu Figueiredo, Porto, Portugal 11.50-12.00 Vote and discussion 12.00-12.20 Do gastric cancers need nerves to develop? Michel Neunlist, Nantes, France 12.20-12.30 Vote and discussion 12.30-12.50 EBV-associated gastric cancer Jaroslaw Regula, Warsaw, Poland 12.50-13.00 Vote and discussion 13.00-14.00 Lunch break Session N 3 Early gastric cancer: diagnosis and treatment Chairman : Tamara Matysiak-Budnik & Jean-François Mosnier 14.00-14.20 Gastric precancerous lesions: Do we have new blood markers? Eliette Touati, Paris, France 14.20-14.30 Vote and discussion 14.30-14.50 Evolution of gastric precancerous lesions: pathologist s point of view: Magali Svrek, Paris, France 14.50-15.00 Vote and discussion 15.00-15.20 How to detect early neoplastic lesions? The place of new endoscopic technics Emmanuel Coron, Nantes, France 15.20-15.30 Vote and discussion 15.30-15.50 Case-based presentation: Endoscopic treatment of early gastric cancer Nicolas Musquer, Nantes, France 15.50-16.00 Vote and discussion 16.00-16.30 Coffee break
Session N 4 Treatment of resectable gastric cancer Chairman: Emmanuel Coron & Yann Touchefeu 16.30-16.50 Staging of gastric cancer: is laparoscopic exploration necessary? Nicolas Regenet, Nantes, France 16.50-17.00 Vote and discussion 17.00-17.20 Surgery of gastric cancer: which type of lymphadenectomy? Magnus Nilsson, Sweden 17.20-17.30 Vote and discussion 17.30-17.50 Nutritional management of patients undergoing surgery: pre- or post-surgery? Adam Jirka, Nantes, France 17.50-18.00 Vote and discussion 18.00-18.20 When and which adjuvant treatment is necessary? Philippe Rougier, Paris, France 18.20-18.30 Vote and discussion
Saturday, 18 th of June Session N 5 Treatment of metastatic gastric cancer Chairman: Estelle Cauchin & Philippe Rougier 8.30-8.50 How to chose chemotherapy: 1 st and 2 nd line, and beyond? Clinical case-based presentation Yann Touchefeu, Nantes, France 8.50-9.00 Vote and discussion 9.00-9.20 Targeted therapies in the treatment of gastric cancer: Where are we now and where do we go? Tamara Matysiak-Budnik, Nantes, France 9.20-9.30 Vote and discussion 9.30-9.50 Surgery for metastatic gastric cancer: is it reasonable? Christophe Mariette, Lille, France 9.50-10.00 Vote and discussion 10.00-10.30 Conference: Medicine of precision: how can it be applied in gastric cancer? Thomas Seufferlein, Ulm, Germany 10.30-10.40 Vote and discussion 10.40-11.00 Coffee break Session N 6 Gastric cancer: what are the new challenges? Chairman: Tomica Milosavljevic & Jaroslaw Regula 11.00-11.20 Gastric cancer as hereditary disease: When onco-genetic consultation is needed? Estelle Cauchin, Nantes, France 11.20-11.30 Vote and discussion 11.30-11.50 Gastro-oesophageal junction cancer: diagnostic and therapeutic challenge? Peter Malfertheiner, Magdeburg, Germany 11.50-12.00 Vote and discussion 12.00-12.20 Can we prevent gastric cancer by eradicating H. pylori? F. Mégraud, Bordeaux, France 12.20-12.30 Vote and discussion 12.30-12.50 Public health measures for preventing gastric cancer: where are we today? Tomica Milosavljevic, Belgrad, Serbia 12.50-13.00 Vote and discussion 13.00 Closing remarks
Hotel Radisson 6 Place Aristide Briand 44000 Nantes «course venue» Tramway stop line : Jean Jaurès Tramway stop P Aristide Brian P Bretagne Tramway stop line : Bretagne P Bretagne Place du Commerce Exposition of stomac model